Earth Science Tech, Inc. (ETST) on Course to Complete White Paper Studies in 2019
ETST will investigate combination drugs that combine a mineral element with full spectrum cannabinoid industrial hemp oil; it anticipates completion of white paper studies in early 2019, with clinical trials to follow Goal is to produce both an OTC nutraceutical product and a cannabinoid companion generic drug to fight the epidemic of opioid dependency Foundations Wellness Center reports that two million Americans are now addicted to opioids Earth Science Tech, Inc. (OTC: ETST) has set 2019 as the crucial year when the company anticipates completion of white paper studies and the start of human clinical trials to investigate the synergies…